Stock-based Compensation (Details) - USD ($) |
1 Months Ended | 12 Months Ended | |||||
---|---|---|---|---|---|---|---|
Apr. 06, 2020 |
Jul. 31, 2021 |
Feb. 17, 2021 |
Dec. 31, 2021 |
Dec. 31, 2020 |
Dec. 31, 2019 |
Jul. 15, 2021 |
|
Stock-based Compensation (Details) [Line Items] | |||||||
Common stock, shares reserved for issuance | 1,302,326 | ||||||
authorized for issuance | 465,116 | ||||||
Increase in issuance of authorized shares | 348,837 | 1,767,442 | |||||
Shares available for future grant | 17,442 | ||||||
Fair value of options granted (in Dollars) | $ 2,100,000 | ||||||
Unrecognized compensation cost (in Dollars) | $ 2,000,000 | ||||||
Weighted average period | 2 years 4 months 24 days | ||||||
Shares of restricted stock units | 26,738 | ||||||
Grant date of fair value (in Dollars) | $ 100,000 | ||||||
Fair value of per shares (in Dollars per share) | $ 3.74 | ||||||
Outstanding of restricted stock units (in Dollars) | $ 54,000 | ||||||
2019 Plan [Member] | |||||||
Stock-based Compensation (Details) [Line Items] | |||||||
authorized for issuance | 232,558 | ||||||
Shares issued for future grants | 75,581 |
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Aggregate number of common shares reserved for future issuance. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of noncash expense for award of restricted stock or unit under share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The maximum number of shares (or other type of equity) that have been approved for issuance in the equity-based payment transaction. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of cost expensed and capitalized for award under share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average grant-date fair value of options vested. No definition available.
|
X | ||||||||||
- Definition The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares of stock issued attributable to transactions classified as other. No definition available.
|
X | ||||||||||
- Details
|